Clinical Trial Update: A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating different dosing schedules of Selinexor in soft tissue sarcoma and related tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Stromal Sarcoma
• Leiomyosarcoma
• Malignant Peripheral Nerve Sheath Tumor
• Soft Tissue Sarcoma

Drugs mentioned

• Selinexor (selinexor)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Soft Tissue Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST) | Phase 1 | Status: COMPLETED